SCHEMBL15870513

SCHEMBL15870513

CN[C@H](c1ccccc1)C(C)(C)O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRK1 P41145 5/20 0.50
HTR2A P28223 2/20 0.45
CHRM2 P08172 1/20 0.45
ADRA1A P35348 1/20 0.45
RGS12 O14924 1/20 0.45
GLA P06280 1/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2D6 P10635 1/20 0.45
CYP2C9 P11712 1/20 0.45
PKM P14618 1/20 0.45
ALOX15 P16050 1/20 0.45
TSHR P16473 1/20 0.45
ALOX12 P18054 1/20 0.45
ADRA2C P18825 1/20 0.45
NFKB1 P19838 1/20 0.45
CYP2C19 P33261 1/20 0.45
THPO P40225 1/20 0.45
GNAI1 P63096 1/20 0.45
HSD17B10 Q99714 1/20 0.45
KMT2A Q03164 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21446955 1.00 OPRK1 (0.50) OPRK1HTR2ACHRM2ADRA1ARGS12
SCHEMBL13464073 0.82 OPRK1 (0.49) OPRK1HTR2ACHRM2ADRA1ARGS12
SCHEMBL6577111 0.79 OPRK1 (0.44) OPRK1HTR2ACHRM2ADRA1ARGS12
SCHEMBL6577107 0.79 OPRK1 (0.44) OPRK1HTR2ACHRM2ADRA1ARGS12
SCHEMBL1953208 0.78 MAPK1 (0.48) OPRK1KMT2ALMNAALDH1A1RIPK1
SCHEMBL4337140 0.78 MAPK1 (0.47) OPRK1KMT2ALMNARIPK1MAPK1
SCHEMBL1421212 0.77 OPRK1 (0.45) OPRK1HTR2ACHRM2ADRA1ARGS12
SCHEMBL12797626 0.77 OPRK1 (0.45) OPRK1HTR2ACHRM2ADRA1ARGS12
SCHEMBL19290647 0.77 OPRK1 (0.45) OPRK1HTR2ACHRM2ADRA1ARGS12
Hydrochloric Acid SCHEMBL7836818 0.76 OPRK1 (0.60) OPRK1HTR2ACHRM2ADRA1ARGS12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2014106606-A1 NOVE PHENYL/PYRIDINE SERIES SUBSTITUED BY HYDROXYETHYLAMINO FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2014-07-10 WO disclosed